Depletion of CD11c+ cells triggered the recruitment of cross-presenting cDC1 into the tumor and a loss of CD11c+ macrophages, resulting in the accumulation of TRP-2 TCR-engineered T cells. This evidence concerns the gene ITGAX and neoplasm.